Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 898

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 5
Chunk 898
---
4, this report has been signed by the following persons in the capacities and
on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/
    Lei Huang
     
    Chief Executive Officer
    and Director
     
    April 1, 2025
  
    Lei Huang
     
    (Principal Executive Officer)

    /s/
    You (“Patrick”) Sun
     
    Chief Financial Officer
     
    April 1, 2025
  
    You (“Patrick”)
    Sun
     
    (Principal Financial and
    Accounting Officer)

    /s/
    Huifeng Chang
     
    Director
     
    April 1, 2025
  
    Huifeng Chang

    /s/
    Jim Mao
     
    Director
     
    April 1, 2025
  
    Jim Mao

    /s/
    Kevin Vassily
     
    Director
     
    April 1, 2025
  
    Kevin Vassily

38

0001913577
false
FY

    0001913577

    2024-01-01
    2024-12-31

    0001913577
    
      deca:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneRedeemableWarrantMember

    2024-01-01
    2024-12-31

    0001913577
    
      deca:ClassAOrdinarySharesParValue00001PerShareMember

    2024-01-01
    2024-12-31

    0001913577
    
      deca:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember

    2024-01-01
    2024-12-31

    0001913577

    2024-06-28

    0001913577
    
      us-gaap:CommonClassAMember

    2025-04-01

    0001913577
    
      us-gaap:CommonClassBMember

    2025-04-01

    0001913577

    2024-12-31

    0001913577

    2023-12-31

    0001913577